drugset / Trial / NCT01038297

Safety and Efficacy Study of Different Dose Levels of EXC 001 to Improve the Appearance of Scars in Subjects Undergoing Elective Abdominoplasty

NCT01038297 ↗

Phase 2 Completed 30 enrolled Pfizer
RandomizedParallel-groupDouble-blindTreatment

Summary

This study will compare how well EXC 001 works versus placebo in reducing the appearance of scars in subjects undergoing elective abdominoplasty. The study will also evaluate the safety of EXC 001 in healthy adult subjects.

Timeline

Start
2009-12-01
Primary completion
2010-07-07
Completion
2010-07-07

Drugs

EvaluationDrugModalityDoseRoute
Subject EXC 001 Unknown — Other

Indications